류마티스 관절염 환자에서 leflunomide 복용 중 발생한 용혈성 빈혈 1예 = Hemolytic Anemia in a Patient with Rheumatoid Arthritis Treated with Leflunomide

다국어 초록 (Multilingual Abstract)

Leflunomide is a new isoxazole based disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis. Leflunomide alone or combination with methotrexate has been reported to be safe as well as effective in patients with rheumatoid arthritis.
Although a few cases of leflunomide-induced pancytopenia were identified, leflunomide-induced hemolytic anemia in rheumatoid arthritis has not been reported yet. We present a case of leflunomide-induced hemolytic anemia in a patient with rheumatoid arthritis.

다국어 초록 (Multilingual Abstract)

Leflunomide is a new isoxazole based disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis. Leflunomide alone or combination with methotrexate has been reported to be safe as well as effective in patients with rheumatoid arthritis.
Although a few cases of leflunomide-induced pancytopenia were identified, leflunomide-induced hemolytic anemia in rheumatoid arthritis has not been reported yet. We present a case of leflunomide-induced hemolytic anemia in a patient with rheumatoid arthritis.

참고문헌 (Reference)

1 김유현, "진단방사선영역에서 방사선장치의 이용실태 및 환자피폭선량에 관한 조사연구" 한국의학물리학회 16 (16): 10-15, 2005

2 Strand V, "Treatment of active rheumatoid arthritis with leflunomide comparedwith placebo and methotrexate" Leflunomide Rheumatoid Arthritis Investigators Group 159 : 2542-2550, 1999

3 McEwen J, "The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate" 16 : 65-73, 2007

4 Kalden JR, "The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study" 48 : 1513-1520, 2003

5 Breedveld FC, "Leflunomide: mode of action in the treatment of rheumatoid ar" 59 : 841-849, 2000

6 Hirabayashi Y, "Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis" 45 : 689-691, 2006

7 Bartlett RR, "Leflunomide, an immunorestoring drug for the therapy of autoimmune disorder, especially rheumatoid arthritis" 28 : 3074-3078, 1996

8 신동혁, "Leflunomide 복용 중 발생한 간질성 폐렴 치료 1예" 대한류마티스학회 14 (14): 268-273, 2007

9 Osiri M, "Leflunomide for the treatment of rheumatoid arthritis: a systematicreview and metaanalysis" 30 : 1182-1190, 2003

10 Leca N, "Higher levelsof leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients" 3 : 829-835, 2008

11 Beutler E, "Drug-induced hemolytic anemia" 21 : 73-103, 1969

12 Nell VP, "Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis" 43 : 906-914, 2004